Clinical Trial Update: The Safety and Efficacy of Ozarelix to Treat Men With Lower Urinary Tract Symptoms Due to Enlargement of the Prostate [Phase 2]

View source ↗

Summary

Phase 2 trial update on the safety and efficacy of Ozarelix for men with lower urinary tract symptoms due to benign prostatic enlargement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hypertrophy

Drugs mentioned

• Ozarelix (ozarelix)

Snippet

Sponsor: Spectrum Pharmaceuticals, Inc | Conditions: Benign Prostatic Hypertrophy | Phase 2 | Status: COMPLETED